Daniil Gataulin
Stock Analyst at Chardan Capital
(4.86)
# 75
Out of 5,131 analysts
117
Total ratings
67.29%
Success rate
44.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 → $1 | $0.59 | +69.49% | 11 | Jan 5, 2026 | |
| ANNX Annexon | Initiates: Buy | $16 | $5.25 | +204.76% | 1 | Dec 23, 2025 | |
| KLRS Kalaris Therapeutics | Initiates: Buy | $19 | $9.78 | +94.27% | 1 | Dec 23, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $11.26 | +86.50% | 4 | Dec 9, 2025 | |
| QURE uniQure | Maintains: Buy | $53 | $25.32 | +109.32% | 11 | Dec 4, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $14.59 | +256.41% | 14 | Nov 20, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $23.88 | +155.44% | 7 | Nov 17, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $27.72 | -49.49% | 4 | Nov 17, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $5.12 | +95.31% | 3 | Nov 14, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $7.41 | +372.33% | 7 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 | $1.93 | +366.32% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 | $23.07 | +121.07% | 9 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $1.50 | +366.67% | 14 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $7.74 | +93.92% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.41 | +183.69% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $16.23 | +66.36% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.69 | +31,728.70% | 1 | Mar 7, 2024 |
Outlook Therapeutics
Jan 5, 2026
Maintains: Neutral
Price Target: $3 → $1
Current: $0.59
Upside: +69.49%
Annexon
Dec 23, 2025
Initiates: Buy
Price Target: $16
Current: $5.25
Upside: +204.76%
Kalaris Therapeutics
Dec 23, 2025
Initiates: Buy
Price Target: $19
Current: $9.78
Upside: +94.27%
Ocular Therapeutix
Dec 9, 2025
Maintains: Buy
Price Target: $21
Current: $11.26
Upside: +86.50%
uniQure
Dec 4, 2025
Maintains: Buy
Price Target: $53
Current: $25.32
Upside: +109.32%
REGENXBIO
Nov 20, 2025
Maintains: Buy
Price Target: $52
Current: $14.59
Upside: +256.41%
Forte Biosciences
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $23.88
Upside: +155.44%
Kodiak Sciences
Nov 17, 2025
Maintains: Neutral
Price Target: $14
Current: $27.72
Upside: -49.49%
Zura Bio
Nov 14, 2025
Maintains: Buy
Price Target: $10
Current: $5.12
Upside: +95.31%
MeiraGTx Holdings
Nov 14, 2025
Maintains: Buy
Price Target: $35
Current: $7.41
Upside: +372.33%
Nov 13, 2025
Maintains: Buy
Price Target: $9
Current: $1.93
Upside: +366.32%
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $23.07
Upside: +121.07%
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.50
Upside: +366.67%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $7.74
Upside: +93.92%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.41
Upside: +183.69%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $16.23
Upside: +66.36%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.69
Upside: +31,728.70%